SYNOPSIS FOR
MS (Ayu.) DISSERTATION
A STUDY TO COMPARE THE EFFICACY
OF AYURVEDIC INTERVENTION WITH THE CONVENTIONAL INTERVENTION IN MANAGEMENT OF
EPISIOTOMY WOUND- A NON-INFERIORITY OPEN LABELLED RANDOMIZED CLINICAL TRIAL
Name of Scholar
Dr.
Sanika Sanjay Aphale
GUIDE CO-GUIDE
CO-GUIDE
Dr. Swati V. Gaikwad Prof. Dr. Sujata D. Kadam Dr. Ruchi Arora
Associate professor Professor and head, Counsultant
Dept of PTSR Dept of PTSR Dept of PTSR
AIIA , New Delhi AIIA , New
Delhi AIIA , New Delhi
DEPARTMENT OF STREE ROGA AND PRASUTI TANTRA
ALL INDIA INSTITUTE OF
AYURVED, NEW DELHI
(An autonomous organisation under the Ministry of Ayush, Govt
of India)
Gautampuri, Saritavihar, New Delhi
-110076
Batch -2023-2026
Enrollment no- 23AIIAMMAM000023
CERTIFICATE
This is to certify that DR. SANIKA SANJAY APHALE, first year PG. (Ayu.) Scholar in the
department of prasuti tantra evam stree roga, All India Institute of
Ayurveda,
New Delhi has proposed her dissertation entitled
“A
STUDY TO COMPARE THE EFFICACY OF AYURVEDIC INTERVENTION WITH THE CONVENTIONAL
INTERVENTION IN MANAGEMENT OF EPISIOTOMY WOUND- A NON-INFERIORITY OPEN LABELLED
RANDOMIZED CLINICAL TRIAL’’who is a bonafide student of this Institute of 2023-2026 Batch.
(PROF.) DR. TANUJA NESARI
Director
All India Institute of Ayurveda
Date:
Place: New
Delhi
TITLE:
A study to compare the efficacy
of ayurvedic intervention with the conventional intervention in management of
episiotomy wound- a non-inferiority open labelled randomized clinical trial
RESEARCH QUESTION :
Whether there is a
difference in efficacy in the management of episiotomy wound by ayurvedic and conventional
interventions?
NULL HYPOTHESIS :
Ayurvedic intervention is
not equally effective than the conventional intervention in the management of episiotomy
wound
ALTERNATE
HYPOTHESIS :
Efficacy of Ayurvedic
intervention is not-inferior to that of the conventional intervention in the
management of episiotomy wound
Introduction:
The disease burden of
puerperal sepsis and its association with maternal mortality is of a great
concern. It accounts for 11% of maternal mortality globally[1]On the
other hand, WHO states that the world is running out of antibiotics and
dedicates the theme for world health day
as ‘‘Antimicrobial resistance:no action today ,no cure tomorrow’’ way back in
2011. Ayurveda has a great potential to not only prevent the incidences of
puerperal sepsis post normal vaginal deliveries but also holistically aid the
smooth transition of puerpera and can in turn contribute effectively in
reducing this crisis of antimicrobial resistance.
Contemporary
Review:
Puerperium is a period following the child birth during which the
anatomical organs and the physiology of body returns back to pre-pregnant
state. The period of puerperium begins after the expulsion of placenta till 6
weeks when the uterus regresses to non-pregnant size.
It is a state of
low immunity due to wounds, lacerations in cervix,vagina,placental site and
blood loss. The presence of a variety of microorganisms in vagina eg
staphylococcus, e coli, clostridium,yeasts etc are likely to become virulent in
this situation owning to lowered immunity. In India, it is a common practice to
give antibiotics after episiotomy as prophylaxis ,maybe due to hygiene
concerns.
Episiotomy
is a surgically planned incision taken on the perinium to facilitate the birth
of the child during a vaginal delivery. There has been a controversy regarding
usage of systemic antibiotics as prophylaxis for normal vaginal delivery
episiotomy ( 2nd degree perineal tear)[2,4]. While some
textbooks recommend the use of systemic antibiotics as prohylaxis in normal
vaginal delivery episiotomy ( 2nd degree perineal tear) others
don’t. As per WHO guidelines oral
antibiotics are not recommended in episiotomy .As
per ACOG practice bulletin, antibiotics are only indicated in 3rd
and 4th degree perineal tear.The DC Dutta textbook of
obstetrics recommend the use of local antibiotic ointment along with oral
analgesics but do not mention the use of systemic antibiotics[3]
Administration of antibiotics may have adverse effect on both mother and
the child. As a well-known fact the use of antibiotics causes a disturbance in
the gut microbial flora which can lead to IBS , hormonal imbalances , metabolic
diseases[7]. It also induces resistance to the antibiotics. The use
of antibiotics in the mother decreases breast milk secretion and it also kills
the good bacterias in vagina which leads to vaginosis of the puerperium.[5]
Some
antibiotics which are relatively safe during lactation are
penicillins,clavulanic acids,cephalosporins,metronidazole at low doses . Analgesics
like paracetamol , low dose aspirin are also considered compatable with breast
feeding. [9]
Classical review
Episiotomy according to ayurved is Sudha
chinna vrana which will follow the principals of vrana chikitsa for
its management.[6]
Sutika,
as described in the classics is a female who has delivered a baby. Sutika kaal
is considered to be of 6 weeks Sushrut[7], ashtang hriday[8] alternatively till the women starts
menstruating, while kashyap mentions a period of 6 months[9] , as
this period is required by the female to gain back the physiological state of
the body.
Sutika Avastha
is a very fragile condition because her body is emaciated due to development of
the fetus and also empty due to blood loss during delivery , vitiation of vaat
due to labour pains. Any disease in this condition would lead to the
diseases that are very difficulty to cure, so all the samhitas have mentioned paricharya
to avoid this from happening.
Thus the management of
episiotomy wound in sutika avastha will require certain modifications in
the treatment protocols mentioned in classics considering this physiological
state. The classics expect vaidyas to use yukti Pramana to
address this.
Review of previous works:
|
Sr
no
|
Study
title
|
Author
|
Drugs
/ methods used
|
Knowledge
gap
|
|
1.
|
Validation
of the effect of an ayurvedic therapeutic procedure, Dashmoolkwath and dhoopan
– fumigation with medicinal herbs during first week of puerperium- an open
clinical trial[10]
|
Dr
Seema R. Gholap
DR
N. V. khairnar
|
Dashmool
kwath,
yoni dhoopana with kushta, aguru,guggulu
|
1)Specificity
of antimicrobial action of dhoopana dravyas used not mentioned
2)
Details about dhoopana upakrama regading the length of dhoopana tube ,
distance from the opening of tube from the wound,temperature of dhoopana not mentioned
3)
REEDA SCALE for episiotomy wound healing not used
|
|
2
|
Determining
the efficacy of combination of three ayurvedic formulations and dhoopana in
prevention of infections post vaginal delivery with episiotomy[11]
|
Dr
Swati Mohite
|
Vidanga,
shatapushpa,jatamansi, guggulu sprinkled on embers and dhoopana done with the fumes.
Balant
kadha
Saubhagya
shunthi paak
Shatavari
kalpa
|
1)REEDA
SCALE for episiotomy wound healing not used
2)Specificity
of antimicrobial action of dhoopana dravyas used not mentioned
3)standardization
regarding temperature of dhoopana not done
|
|
3
|
Clinical
efficacy of local guggulu dhoopana in management of episiotomy wound[12]
|
Dr
Garthe limbanappa Somnath
Dr
Ravikiran Ram Bhosale
|
Ghrita
and guggulu dhoopana
|
1)laboratory
investigations not done to support the clinical findings
|
|
4
|
Evaluation
of Dhoopana karma in sutika paricharya[13]
|
Dr
Vidyaa Maruti Magar
Dr
S R Gholap
|
Kushta
,aguru,guggulu
dhoopana
|
Specificity
of antimicrobial action of dhoopana dravyas used not mentioned
|
|
|
|
|
|
|
Need of research :
1. The
research work done previously show that episiotomy can be managed by ayurvedic
regimen but the spectrum of antimicrobial action is not mentioned clearly.
2. If
ayurvedic regimen has to be implemented in episiotomy wound management, more
RCTs taking antibiotics as the comparator group is needed in order to have a
thorough comparative analysis
Primary
objectives:
.To study the efficacy of
ayurvedic intervention in episiotomy wound management and compare its effectiveness
with the conventional intervention.
Secondary
objectives:
1. To
assess the effect of yoni dhoopana on lochia
2. To
assess in-vivo antimicrobial action of the formulations used
3. To
examine the possible mode of action of the upakrama and dravyas used
4. To
examine adverse effects if any
Outcome measures:
PRIMARY
OUTCOME:
1) Healing
of episiotomy wound
SECONDARY
OUTCOME:
1)
Reduction in the colony count of bacterias
2)
Decrease in pH of lochia
Materials and
methods
Plan of Study-
1) Literature
review-
-
Drug Review
-
Episiotomy Wound healing Review
2) Pharmaceutical review-
-
Procurement of RAW material
-
Identification and authentication of Raw
drugs
3) Clinical
study
Drug review:
Triphala guggulu –
will be procured from GMP certified pharmacy
अथ तà¥à¤°à¤¿à¤«à¤²à¤¾
गà¥à¤—à¥à¤—à¥à¤²à¥à¤°à¥à¤à¤—नà¥à¤¦à¤°à¤¾à¤¦à¥Œ –
तà¥à¤°à¤¿à¤ªà¤•à¥à¤·à¤‚
तà¥à¤°à¤¿à¤«à¤²à¤¾à¤šà¥‚रà¥à¤£à¤‚ कृषà¥à¤£à¤¾à¤šà¥‚रà¥à¤£à¤‚ पलोनà¥à¤®à¤¿à¤¤à¤®à¥ ।
गà¥à¤—à¥à¤—à¥à¤²à¥à¤‚ पाञà¥à¤šà¤ªà¤²à¤¿à¤•ं
कà¥à¤·à¥‹à¤¦à¤¯à¥‡à¤¤à¥à¤¸à¤°à¥à¤µà¤®à¥‡à¤•तः ॥ ८२ ॥
ततसà¥à¤¤à¥ गà¥à¤Ÿà¤¿à¤•ां
कृतà¥à¤µà¤¾ पà¥à¤°à¤¯à¥à¤žà¥à¤œà¥à¤¯à¤¾à¤¦à¥à¤µà¤¨à¥à¤¹à¥à¤¯à¤ªà¥‡à¤•à¥à¤·à¤¯à¤¾ ।
à¤à¤—नà¥à¤¦à¤°à¤‚ गà¥à¤²à¥à¤®à¤¶à¥‹à¤¥à¤¾à¤µà¤°à¥à¤¶à¤¾à¤‚सि च विनाशयेतॠ॥ ८३ ॥
( शा.सां.म.खां.82-83
)
|
Sr no
|
Name of ingredient
|
Latin name
|
family
|
Part used
|
|
1
|
Haritaki
|
Terminalia chebula Retz.
|
Combretaceae
|
Fruit
|
|
2
|
Amalaki
|
Phyllanthus emblica L.
|
Euphorbiaceae
|
Fruit
|
|
3
|
Bibhitaki
|
Terminalia bellirica Retz.
|
Combretaceae
|
Fruit
|
|
4
|
Pippali
|
Piper longum linn.
|
piparaceae
|
Fruit
|
|
5
|
Guggulu
|
Commiphora wightii Linn.
|
Burseraceae
|
Resin
|
|
|
|
|
|
|
Dhoopan Dravya :
|
Sr no
|
Name of ingredient
|
Latin name
|
Family
|
Parts used
|
|
1
|
Sarjarasa
|
Vateria indica Linn
|
Dipterocarpaceae
|
Resin
|
Procurement :The drug
will be procured from the market
Authentication: The drug
will be authenticated from Pharmacognosy lab, AIIA, New Delhi
Jatyadi Tail:
will be procured from GMP certified pharmacy
जातीननमà¥à¤¬à¤ªà¤Ÿà¥‹à¤²à¤¾à¤¨à¤¾à¤¾à¤‚
नकà¥à¤¤à¤®à¤¾à¤²à¤¸à¥à¤¯
पलà¥à¤²à¤µà¤¾à¤¾à¤ƒ
।।
168
।।
नसकà¥à¤¥à¤¾à¤‚समधà¥à¤•ां
कà¥à¤·à¥à¤ ां
दà¥à¤°à¥‡à¤¨à¤¨à¤¶à¥‡à¤•टà¥à¤°à¥‹à¤¨à¤¹à¤£à¥€
।
पदà¥à¤®à¤•ां
लोधà¥à¤°à¤®à¤à¤¯à¤¾
नीलमà¥à¤¤à¥à¤ªà¤²à¤®à¥à¥¤à¥¤
169।।
तà¥à¤¤à¥à¤¥à¤•ां साररवा
बीजांनकà¥à¤¤à¤®à¤¾à¤²à¤¸à¥à¤¯
दापयेतà¥à¥¤
à¤à¤¤à¤¾à¤¨à¤¨ समà¤à¤¾à¤—ानन
नपषà¥à¤Ÿà¥à¤µà¤¾
तलैनवपाचयेतà¥à¥¤à¥¤
170।।
नाडीवà¥à¤°à¤£à¥‡à¤¸à¤®à¥à¤¤à¥à¤ªà¤¨à¥à¤¨à¥‡à¤¸à¥à¤«à¥‹à¤Ÿà¤•ेकचà¥à¤›à¥à¤°à¥‹à¤¨à¤—षà¥à¥¤
सदà¥à¤¯à¤¾à¤ƒ शसà¥à¤¤à¥à¤°à¤ªà¥à¤°à¤¹à¤¾à¤°à¥‡à¤·à¥à¤¦à¤—à¥à¤§à¤¨à¤µà¤¦à¥à¤§à¥‡à¤·à¥à¤šà¤µ
नह
।। 171 ।।
नखदनà¥à¤¤à¤•à¥à¤·à¤¤à¥‡à¤¦à¥‡à¤¹à¥‡à¤µà¥à¤°à¤£à¥‡à¤¦à¥à¤·à¥à¤Ÿà¥‡à¤ªà¥à¤°à¤¶à¤¸à¥à¤¯à¤¤à¥‡à¥¤
(शा.सां.म.खां.
9/168-17)
Contents
of Jatyadi Tail
STUDY DESIGN- Open
labelled randomized clinical trial
STUDY TYPE-
Interventional
TIMING- Prospective
DURATION-7 days
DRUG FREE FOLLOW UP-14th,45th
day after vaginal delivery
END POINT- Healing of episiotomy
wound
SAMPLE SIZE- 60 ( 30 in
each group )
RANDOMIZATION: Variable Block Randomization
Plan of study:
Time- Within 24hrs of
Normal vaginal delivery
Treatment plan : A) Internal Medication
B) local treatment
A) Internal
Medication- Tablet triphala guggulu 500mg twice a day before food
B) Local
treatment – The following treatment will be done twice a day for 5 days
STANDARD OPERATIVE PROCEDURE FOR DHOOPANA-
{
To be done twice daily at the interval of 10-12 hrs}
Patient is asked to evacuate the bladder and
bowel before therapy
Cleaning the episiotomy wound with Sterile
water in lithotomy position and drying it
New disposable sheets will be used for
every patient on each day of dhoopana
5gm of sarjarasa powder will be sprinkled on 75gm of red hot
charcoal with 5ml of
ghee in a mud pot
(shaarav) until sufficient
quantity of fumes are created
Patient
is made to sit on a wooden chair having diameter of approximately 30cm
such that the episiotomy wound on the perineum is
exposed to the fumes.
The distance of perineum will be
approximately about
50cm ( janu tulya aasan ) from the upper border
of shaarav
Dhoopana
will be done for 5-7 mins
STANDARD OPERATIVE PROCEDURE FOR
APPLICATION OF JATYADI TAIL:
{ To be done twice daily at the interval of
10-12 hrs}
After
the dhoopana, patient will be given lithotomy position
Autoclaved
jatyadi oil will be taken on a gauze in sufficient quantity according to
the size of wound ( approximately 15-20 ml)
The
gauze will be placed over the episiotomy wound and will be removed after 5
mins.
|
GroupA
(Control
group)
|
Tb
Cefuroxime and clavulanic acid twice a day
Tb
Aceclofenac 100mg+ Paracetamol 325mg+ Serratiopeptidase 15mg three times a
day
Betadine
ointment and solution for local application
|
|
Group
B
(Trial
group)
|
Yoni
Dhoopan with sarjarasa, local application of jatyadi tail done
twice daily and tb triphala guggulu 500mg twice a day before food
|
Drug Delivery
Regimen:
|
GROUP
|
DRUG
|
ROUTE
AND DOSE OF ADMINISTRATION
|
DURATION
|
|
A
|
Tb
Cefuroxime and clavulanic acid
|
Oral
– twice a day- after food with water
|
5
|
|
|
Tb
Tb Aceclofenac 100mg+ Paracetamol 325mg+ Serratiopeptidase 15mg
|
Oral
– twice a day- after food with water
|
7
|
|
|
Betadine
solution and ointment
|
Local
– As per size of episiotomy
|
7
|
|
|
Tb
Triphala guggulu 500mg
|
Oral
– twice a day- after food with water
|
7
|
|
B
|
Sarjarasa
dhoopana
|
Local
– As per size of episiotomy
|
5
|
|
|
Jatyadi
tail
|
Local
– As per size of episiotomy
|
7
|
Duration of trail –
7
days
Follow up period –14th
, 45th days
sample size --
As per the practices at AIIA, we have seen at
least 90% success rate in achieving complete wound healing, where as pervious
clinical trials suggest 85% success rate in achieving complete wound healing
using ayurvedic intervention. However, we wish to explore if ayurvedic
intervention can replace the conventional intervention. Therefore, a
non-inferiority clinical trial is being conducted. It is assumed that the
proposed ayurvedic intervention may help to achieve complete healing in 85% of
cases, assuming 10% non-inferiority margin, 80% power , 5% level of
significance
The calculated sample
size in each group is 60 (67 with 10% drop out)
Due to time constraint,
the sample size will be taken as 60 (30 in each group)
Enrollment Of
Patients:
All the patients will be
enrolled from Labour room and ANC OPD of All India Institute of Ayurved, New
Delhi.
Inclusion criteria:
1.
Patients of age group 20-40 years of age
2.
Patients with normal vaginal delivery with
episiotomy( 2nd degree perineal tear)
ICD 11:
ICD 11
code for episiotomy is JB44.1- Disruption of perineal obstetric wound
The following synonyms
will be excluded –
-
Obstetrical breakdown of perineum
-
Disruption of perineal laceration repair
in puerperium
-
Wound dehiscence
Exclusion
criteria:
- Post operative LSCS patients
- Patients having asthma, COPD, dust
allergies
- Patient having 3rd and 4th degree tear,
paraurethral tear
4.
Patient with DM, severe anemia[hb<8gm/dl], other immunocompromised conditions.
5.
Patients with vaginosis , vaginitis, cervicitis or PID
6.
Breast abscess, mastitis
7.
Patients not willing to participate
Investigations
before treatment:
CBC with ESR,
APTT,PTINR,
LFT,KFT,
RBS F, RBS-PP,
URINE Routine -Microscopy,
HIV ANTIBODY 1 and 2,
Anti HCV,
HBsAG, VDRL.
Parameters for assessment
:
A. PAIN
SCALE- ( assessed on 0,1,2,3,4,5 days
post-NVD) [14]
B. CBC
WITH ESR(0th ,5th day)
C.Swab culture(0th ,5th
day)
D.ph
of lochia(0th to 5th day post NVD)
E.REEDA
CRITERIA-(0th, 3rd,5th)[15]
F.
Quantity of Lochia-( 7 consecutive days post NVD )[16]
|
Points
|
Redness
|
Edema
|
Ecchymosis
|
Discharge
|
approximation
|
|
0
|
None
|
None
|
None
|
None
|
Closed
|
|
1
|
<0.25cm of incision bilaterally
|
<1cm from incision
|
<0.25cm bilaterally or 0.5cm unilaterally
of incision
|
serous
|
Skin separation <3mm
|
|
2
|
<0.5cm of incision bilaterally
|
1-2cm from incision
|
<0.25cm-1cm bilaterally or 0.5cm-2cm
unilaterally of incision
|
serosanguinous
|
Skin and subcutaneous fat separation
|
|
3
|
>0.25cm of incision bilaterally
|
>2 from incision or affects vulvar
area
|
>1cm bilaterally or 2cm unilaterally
of incision
|
Bloody purulent
|
Skin and subcutaneous fat separation
|
Healed :0 Moderately healed:1-5 Mildly Healed :6-10 Not
healed:11-15
|
DAYS
PARAMETERS
|
0th
day
|
3rd
day
|
5th
day
|
|
REEDA
|
|
|
|
|
WBC
COUNT
|
|
-------------
|
|
|
ESR
COUNT
|
|
--------------
|
|
Table : assessment parameters
|
PARAMETERS
DAYS
|
PAIN
|
pH of LOCHIA
|
|
PADS
STAINED PER DAY
(280mm)
with nature of discharge
|
|
|
Before
dhoopana
|
After
dhoopana
|
Before
dhoopana
|
After
dhoopana
|
Involution
of uterus below umbilicus
|
|
0
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
2
|
|
|
|
|
|
|
|
3
|
|
|
|
|
|
|
|
4
|
|
|
|
|
|
|
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Table
: assessment parameters
Assessment of
result:
· The data
would be presented in the form of Descriptive Statistics such as Mean ± SD, SEM
or Range etc., whichever is applicable. The data would be depicted in the form
of Tables, Charts, Graphs, Diagrams etc., wherever it is
applicable. Data related to all the intend to treat participants
would be considered for safety related assessments and those completing the
course of treatment (Per protocol) would be considered for efficacy assessment
· The data
generated is subjected to normality test with Shapiro- Wilk test. If normality
test is passed, parametric test would be employed otherwise non parametric test
is employed.
· For
objective data, paired‘t’ test will be employed to assess before and after
treatment differences within the groups and unpaired ‘t’ test will be employed
for assessing the differences within the groups.
· For
subjective data, Wilcoxon signed rank test will be employed to assess before
and after treatment differences within the groups.
· Mann-
Whitney U test will be employed for assessing the difference between the trial
and control groups.
· For
multiple comparisons of more than 2 sets within the same group – repeated
period of ANOVA for parametric data and Friedman’s test for non-parametric data
would be used.
· P valve ≤
0.05 will be considered as statistically significant.
· IBM SPSS
Statistics application for Windows, version 26 will be used for analysis.
· Clinical
effect size would also be determined using design appropriate methods
Investigations:
1)CBC
WITH ESR (0th ,5th day )
2) swab culture (0th,5thday)
3) Ph of lochia (5 consecutively days post
NVD)
Withdrawal
criteria:
1.
Signs of sepsis (temp>100.4 F, pulse
rate>90bpm, subinvoluted and tender uterus , wbc count more than 12000cumm)
2.
Purulent or Blood stained lochia
3.
Breast abscess, mastitis
ADR Reporting:
Adverse drug reaction
will be reported to Pharmacovigilance centre of AIIA,New Delhi
Translational
Value:
- Reducing the burden of antibiotic
resistance
- Protecting the child and the mother
from adverse effects of systemic antibiotics
- Holistic management of sutika
by ayurvedic regimen
- Cost effectiveness
Rescue medication: Patient
will be withdrawn from trial group and will be given antibiotics and painkillers
or resuturing if needed
Patient Compliance
: A patient
information sheet will be provided to patient in printed format. Information
regarding the purpose, treatment plan, benefits and possible risks will be
explained to the patient individually. Patients will be admitted in the ward
for 5 days.
Drug Compliance : A drug compliance chart will be given to the
enrolled patients.
Data
Confidentiality : Data collected during the study will be
stored securely and will be used for analysis.
The Researcher, guide and
co-guides, IEC, AIIA, New Delhi and other regulatory bodies will have access to
the records.
Provision for
Continued Patient Care: The patient will be handed over to
the primary consultant for other routine medications (if required)
Monitoring of
Study: Study
will be monitored by the IRB committee, scholar, guide and co-guides
References:
1. Kaur H, Kaur
S, Mattu S, Nandrajog A. Burden of puerperal sepsis
and its relation with maternal mortality. International Journal of Reproduction,Contraception,Obstetrics,Gynecology
2023;12:3103-8
2. Thitipong
S. Incidence of postpartum infections and outcomes associated with antibiotic
prophylaxis after normal vaginal delivery 2019,58;233-43
3.
Dutta D.C, Textbook of obstetrics, Operative obstetrics,episiotomy,10th
edition,New Delhi:Jaypee brothers
medical publishers,2023;p.259
4. Mohammed NA,Hanafy NM,effect of post
episiotomy antibiotics on maternal infectious morbidity, JRAM,2022;3(1);31-37
5. Chenyang Ji,Geer Zhang,Siyuan Xu,Qingyi Xiang,Meishuang Huang,Meirong Zhao et al.Antibiotic
treatments to mothers during the perinatal period leaving hidden trouble on
infants, European Journal of Pediatrics,2022;181(9):1-13
6. Shastri
A D,editor,(1st ed.), Sushrut Samhita ,poorvardha, chikitsasthan, Chapter
2, verse 10. Varanasi: Choukhamba Sanskrit Sansthana ,2019; p.19
7. Shastri
A D,editor,(1st ed.), Sushrut Samhita ,poorvardha, sharirsthan, Chapter
10, verse 18.Varanasi:Choukhamba Sanskrit Sansthana,2019;
p.103
8. Shastri HS,editor,(1st
ed.),Commentary by Arundutta and
Hemadri on Ashtanga Hridayam of Vagbhata, Sharirsthan,Chapter10,verse 100/101,
Varanasi:Choukhamba Sanskrit Sansthana,2022;p.102.
9. Shaarma
H,Vridhajivaka,Kashyap samhita,revised by vatsya with Sanskrit introduction
with vidyotini hindi commentary,khilsthana,chapter 11,sutikupakramaniya,12,Varanasi:Choukhamba
Sanskrit Sansthana,2000; p.211.
10. Gholap SR, Nar NV. Validation
of the effect of an Ayurvedic procedure, Dashmoolkwath, and Dhoopan –
fumigation with medicinal herbs during the first week of puerperium: An open
clinical trial. Int J Ayurveda Med Sci. 2017;2(2):146-152.
11.
Mohite S.Determining
efficacy of Combination of three ayurvedic formulations and dhoopana (medical
fumigation in prevention of infections
post vaginal delivery with episiotomy), International Journal of Science and
Research January 2013 ;4(1):2319-7064
12. Garthe, L. S., & Bhosale, R. R. Clinical
Efficacy of Local Guggulu Dhoopana in Management of Episiotomy
Wound. Ayurlog: National Journal of Research in Ayurved Science,2021; 9(03).
13. Magar
V and Gholap S , Evaluation of dhupan
karma in sutika paricharya. World journal of pharmacy and pharmaceautical
sciences , 2017; 6(03):
607-621
14. Bird
SB, Dickson EW. Clinically significant changes in pain along the visual
analogue scale,200;,38:639-643
15. Rev
Lat Am Enfermagem, Episiotomy healing assessment : REEDA scale reliability
2015;23(1);162-168
16. Hitmer T. Physical and psychologic
changes. In: Mattson S, Smith JE, editors. Core curriculum for maternal-newborn
nursing. 4th ed. St. Louis, MO: Saunders Elsevier 2011; p. 301-314.
|